A partnership policy with the pharmaceutical industry
Research conducted within Montpellier SIRIC is based on strong partnerships with pharmaceutical companies. This collaboration represents a major strategic factor and is an essential ingredient in the development of new research perspectives.
In areas of mutual interest, the expertise and know-how of academic teams fulfil the needs of industrial partners and contribute to public and private scientific co-production. Futhermore, the access to innovative molecules is made possible thanks to these partnerships, in particular during the early phases of clinical trials.
New companies arising from research
Testifying to the dynamism of the Montpellier SIRIC team’s research, innovative biotechnology companies have been created out of its research laboratories’ findings. Fundamental discoveries made by these academic laboratories will be able to find a wide range of applications for patient care in the future.